Chronic vulval pain can have multi-factorial causes. One of its leading causes, vulvar vestibulitis, is reviewed. A study of vulvar vestibulitisÐ its epidemiology, aetiology, histopathology, diagnosis and treatment is undertaken. More research is needed on this condition as it is important to make an accurate diagnosis and thus raise awareness before providing proper treatment.
INTRODUCTION
Women with vulval pain are a group which often engender a feeling of`heart sink' in those practitioners whom they see. The causes of chronic vulval pain are multi-factorial and patients frequently have little or nothing to ® nd on examination. However, it is important to make an accurate diagnosis in order that patients can be given an explanation for their symptoms and receive appropriate treatment. One of the leading causes of chronic vulval pain is vulvar vestibulitis.
This syndrome was named by Friedrich in 1987 1 to describe the symptom of severe pain on vulvar vestibular touch or during attempted vaginal entry, associated with tenderness to pressure of the vestibule and the ® nding of vulvar erythema. However, there are earlier references to a condition of`excessive sensitivity' or`hyperesthesia' of the vulva in classic texts from the late 1800s 2, 3 . It is reserved for those with symptoms for more than 6 months. Cases can be split into primary Ð pain from ® rst attempted vaginal entry, and secondary, where sexual relations had previously occurred without discomfort, and severity can be divided into 3 levels 4 : I Causes discomfort but does not prevent sexual intercourse II Sometimes prevents sexual intercourse III Completely prevents sexual intercourse Since its original description, several studies have been undertaken to investigate this condition but the aetiology remains unclear, the most appropriate treatment controversial and the majority of cases probably remain undiagnosed.
EPIDEMIOLOGY
The epidemiology of this condition is not well described. Studies suggest the age range is most commonly 20± 30 years 5 , but age ranges vary depending on the group investigated and there have been no population-based studies to determine prevalence. In particular, as patients often present years after onset of symptoms 6 , this may skew results towards the older age groups. Prevalence was found to be 15% in a private practice gynaecology clinic 7 (although these data cannot be extrapolated to the population as a whole because only the higher social classes are likely to be able to afford to visit such a clinic) and 1.3% in a female genitourinary medicine clinic population rising to 10% in those patients complaining of vulval pain 8 . Of 40 volunteers responding to a newspaper advertisement for vulvoscopy, vestibulitis and vestibular erythema was present in 17 (43%) 9 .
It has been noted that the condition is more common in Caucasians. A study of 24 patients found 22 (98%) were Caucasians, one Afro-Caribbean and one Mediterranean, whereas the clinic population was 40% Afro-Caribbean 10 . Friedrich also noted a decreased incidence of African± Americans and it is unclear whether this indicates a genetic predisposition or re¯ects differing socio-cultural behaviour. Social class may also be important with 21 of the 24 belonging to social class I or II in Furlong's study 10 . misdiagnoses and inappropriate treatment. It is important to distinguish between acute vulval vestibulitis which is usually due to acute infection 4 and chronic vulval vestibulitis, in which symptoms have been presented for more than 3 months. Studies by Bazin 11 and Furlong 10 have found candidiasis in 8.8% of 57 patients and 25% of 24 respectively, whereas Peckham 12 found a higher prevalence of 67%, but only 9 patients were included. Mann obtained a history of recurrent candida in 80% of cases 13 versus 21% of controls and Freidrich 14 also had a high proportion (63%) of patients with recurrent candida. Ashman and Ott 15 proposed that antigens of Candida albicans are cross-reactive with vulvovaginal tissue antigens resulting in`responses against self' triggered by hormonal factor or stress, but Marinoff and Turner were not able to demonstrate a delayed hypersensitivity reaction to candidal antigen by intradermal testing 16 . Problems with implicating candida are that diagnoses are usually presumptive and not microscopically con® rmed, and a histological study of 6 cases found no fungi on silver stain 17 . Some postulate that it may in fact be the frequent use of anti-candidal cream by such patients that results in subsequent vulvar vestibulitis rather than candida itself 18 . However, in a study patch testing 13 patients with vulvar vestibulitis who complained of stinging after application of anti-candidal cream, none were found to have irritant or allergic reactions 16 , although these agents may aggravate existing vulvar vestibulitis.
A bacterial aetiology has also been proposed. Vaginal Gardnerella was found in Bartholin's glands in 14% (10) and Ureaplasma in 17.5% (12) of Bazin's cases 11 and clue cells in vaginal secretions of 4 of 24 patients 10 . Some of Sonnex's cases had microscopic features suggestive of desquamative vaginitis 6 . Others have found no association with Neisseria gonorrhoeae, Gardnerella, herpes simplex virus or cytomegalovirus 19 . The evidence of cross immunity to extra-genital trichomonas infection or trichomonas infection of the sexual partners' sperm as a causation factor 20 , has not been con® rmed by other studies 16 .
Several studies have looked at the human papillomavirus (HPV) as an aetiological agent with con¯icting results about its role as a causative factor. Bornstein 19 found HPV in 46 of 86 cases (54%) undergoing perineoplasty compared with one of 25 controls, but of those with HPV, they were not of types 6, 11, 16, 18 or 33 on DNA hybridization. Other authors have found the presence of HPV in 7 of 7 patients (100%) (one with HPV type 6) 21 , and 11 of 13 (85%) (6 with types 16 or 18). However, in the latter study all patients who were biopsied had acetowhite of the vulva, which is known to be associated with subclinical HPV in some cases.
In contrast Wilkinson found only 3 of 21 cases (14.3%) were HPV positive by polymerase chain reaction (PCR) (types 11 (2) or 16 (1)) 22 and in a larger series only 3 of 57 (5.3%) had HPV detected 11 . Yet another study found none of 11 patients to have HPV DNA despite one having koilocytosis (although only HPV types 6/11 were tested for) 23 ; and testing of 36 patients using in situ hybridization (for HPV 6, 11, 16, 18, 31 and 35) resulted in no virus being found 17 .
Other non-infective aetiologies have been proposed as causing, contributing to or being associated with vulvar vestibulitis. Topical anti-fungal therapy has been discussed above. Vulvar vestibulitis syndrome has been found to occur after the vulvitis following treatment with 5-¯urouracil has resolved, although the reason for this is not clear 24 .
Laser therapy for genital warts may result in vulvar vestibulitis even when there is no evidence of scarring 24 but these cases generally have a good prognosis. An association has been found with those commencing the oral contraceptive pill before the age of 17 years (RR 11) compared with those who have never used it, as well as a 3-fold risk in those with coitarche at age 15 years or younger 11 .
Other proposed causes are the irritant effect of alkaline vaginal discharge due to oestrogen de®cits, severe cervicitis and decrease or absence of lactobacillus as in bacterial vaginosis 24 . Irritants such as soaps (which are alkaline), detergents, douches etc. may cause vulvar vestibulitis 24 but more often result in a generalized vulvitis. Urinary calcium oxalate crystals have also been proposed as a causative factor in a case report 25 . This was further investigated by Poole, who found no evidence of abnormal urinary tract excretion of oxalate 26 , although a low oxalate diet resulted in an improvement in symptoms in a number of women.
Other suggested associated conditions include previous systemic chemotherapy, lichen sclerosis, irritable bowel syndrome and intestial cystitis although further evidence and mechanisms of action need to be determined.
HISTOPATHOLOGY
Histological studies appear to be of little value in diagnosis except to exclude other pathology. Biopsies are non-diagnostic and show non-speci® c in¯ammation, mild hyperplasia or are normal 27 . More detailed work on perineoplasty specimens from 36 cases showed all had evidence of chronic in¯ammation with the in® ltrate consisting predominantly of T lymphocytes and plasma cells, mainly in the squamous mucosa 17 . In¯ammation also involved the periglandular/periductal connective tissue of the minor vestibular glands, but to a lesser degree. However, a recent study comparing the histology of the vulvar vestibule in patients with vestibulitis compared with controls, found sub-epithelial in¯ammatory cells were also present in controls and they concluded that this was a normal ® nding and not indicative of vulvar vestibulitis 28 . More detailed neuropathological studies utilizing electron microscopy of vestibular tissue have found intraepithelial axons present in the ducts of vestibular glands, where they are closely applied to serotonin-containing neuroendocrine cells. This close association, and the presence of substance P (involved in neurogenic in¯ammation), indicates a possible role in symptomatology 29 . Vestibular nerve ® bre proliferation in patients compared with controls has also been found. Concentrations of both interleukin-1 beta and tumour necrosis factor-alpha have both been shown to be elevated in women with vestibulitis, although paradoxically the levels were lowest in the area of highest hyperalgesia 30 .
OTHER ASSOCIATIONS
Some authors perceive vulvar vestibulitis not as a discrete disease process but as part of a disorder of urogenital sinus-derived epithelium. Interstitial cystitis has been described in 3 women with vulvar vestibulitis 31 , an association proposed because of the derivation of vulvar vestibule and bladder from the urogenital sinus. Additionally, increased urethral pressure variability has been found in patients with vulvar vestibulitis syndrome, probably due to variation in urethral muscular tone 32 . A possible variant of vestibulitis which affected the vagina has been described 33 but the signi® cance of this ® nding is unknown.
PSYCHOPATHOLOGY AND PSYCHOSEXUAL CONSEQUENCES
As an undifferentiated group, women with dyspareunia have more psychological symptomatology, more negative attitudes toward sexuality, higher levels of impairment in sexual function and lower levels of marital adjustment, compared with controls but when this is divided in to sub-types, Meana found women with vulvar vestibulitis were no different to controls regarding psychological symptomatology 34 . However, they had signi® cant sexual impairment in all phases of the sexual response cycle, as well as negative attitudes towards sexuality. In contrast, considerable psychological dysfunction compared with controls was found by Nunns 35 . Women with vulvar vestibulitis have been found to score higher on somatazation and shyness subscales than a normal population but had no difference in regard to psychological distress, extrovertism, risk of psychopathology and marital satisfaction. There was, however, more frequent problems with arousal, lubrication and negative emotions in the sexual interaction with their partner 36 . Vaginismus is often a complicating factor and has been found in 50± 60% 37,38 of cases, and this may have prognostic value.
Although little work has been done on the partners of women with vulvar vestibulitis, they have been found to have signi® cantly lower scores for psychopathology than a normal population 36 , and report nearly no problems or distress in a sexual situation.
DIAGNOSIS
The diagnosis of vulvar vestibulitis is based on a combination of symptoms and clinical signs. Typically, patients complain of vulvar soreness or pain. This is often precipitated by sexual intercourse, tampon insertion or the wearing of tight/ restricted clothing in the genital area. On examination patients have macroscopic erythema of the vulvar vestibule with point tenderness on the application of a cotton-tipped swab 1 .
Other diagnostic methods have included biopsy which is unhelpful except to exclude other conditions (see above) or the use of vulvoscopy. Typically, 3± 10 mm areas of focal erythema are visible, in most cases without swelling or ulceration. These lesions are exquisitely tender, whereas the contiguous mucosal surface is normal in appearance and non-tender 12 . Acetowhitening may or may not be present 39 .
TREATMENT
As the aetiology is unclear, so is the management. As can be expected when there is multiplicity of treatments, none are effective in all cases and it is often a case of trying various options. Treatment successes are often anecdotal with few (if any) randomized controlled trials comparing treatments with placebo or with each other. Treatment can be divided into 5 groups; supportive, symptomatic, medical, surgical and psychological.
Supportive
The ® rst and essential method of management is explanation and reassurance. Women have frequently been led to believe that there is nothing wrong with them 6 and it is`all in their mind' (personal observations). Merely being given a diagnosis is often a relief both to themselves and their partners. Marinoff and Turner 24 recommend that physicians should be`supportive, accessible, understanding and constantly on the lookout for a speci® c cause' and highlight the need to`manage the disease and not succumb to use of aggressive therapies' unless indicated.
Symptomatic
A number of cases will resolve spontaneously, although there have been no long-term prospective studies. The application of aqueous creams may provide relief and topical anaesthetics can be applied 30 min before intercourse. The use of lubricating agents, particularly newer types such as Senselle may also be useful.
Medical
Topical treatments that have been found anecdotally to be useful include steroids, sometimes in combination with other agents (e.g. Trimovate, Triadcortyl) 6 , metronidazole gel, analgesics, lubricants, soaks of Burrows, Benzydamine, Aveeno oilatum and aqueous lidocaine. Intralesional injections of triamcinolone may also be of value 6 .
If recurrent candidiasis is thought to be a causative factor, oral anti-candidal agents should be tried. Other oral agents that may be useful include steroids and antihistamines and topical Ketoconazole 40 , but a trial of acyclovir found it to be of no value 14 . Treatment of vaginal infections such as bacterial vaginosis, Ureaplasma or Bhaemolytic streptococcus can result in cure (personal observation) and if desquamative in¯ammatory vaginitis is present, clindamycin can cause marked improvement 6 . Dietary alterations to reduce oxalate in urine have been useful in some cases 25, 26 . Amitriptyline in low dose, although useful with essential vulvodynia 41 has not been effectively studied in patients with vulvar vestibulitis. In older patients, oestrogens applied topically or hormone replacement therapy may be of value.
Interferon therapy has been assessed with variable results, using a or B interferon, intralesionel or intramuscular. Favourable results were found by Horowitz 42 and Hatch 43 in patients with coexistent HPV, with improvement in 15 of 17 and 16 of 22 respectively. However, results from Umpiere 44 were less impressive with only 5 of 13 having a resolution of symptoms. Marinoff had a favourable response in only 49% and found this was irrespective of presence of histological HPV changes, but results still suggested that this was a cost effective alternative to immediate surgery 45 . The role of laser therapy has not been proven and has mostly been disappointing 13, 14, 46 .
Other approaches include electromyographic biofeedback of pelvic¯oor musculature to reduce hyperactivity of the pelvic¯oor muscles, which has been used by physical therapists and psychologists. This can result in increased pelvic¯oor muscle contractions, decreased muscle resting tension level and subjective decreases in pain of 83% 47 . Following this therapy, 22 of 28 patients were able to resume sexual intercourse and 17 reported painfree intercourse.
Surgical
Surgical treatment is usually a last resort with variable success rates according to procedure, but results of trials are dif® cult to compare as response is often graded as complete or partial and length of follow-up is variable. Perineoplasty or modi® ed perineoplasty has been the surgical treatment of choice, with success rates of up to 100% 38, 45, 48 . Simpler surgery such as vestibular revision, undertaken under local anaesthetic, has recently been found to result in complete resolution in 10 of 12 patients 49 . Surgery compared favourably with interferon therapy in Mann's study of 56 patients undergoing perineoplasty, where 16 (29%) were completely better and 21 (37%) were much improved 13 compared with interferon therapy where 5 of the 13 (38%) were much improved. Further discussion of surgery is beyond the scope of this article. Further information can be obtained from reviews by Marinoff 4 and Bergeron 50 .
Psychological
Psychological treatment may be useful in conjunction with other therapy. Shover in a study on psychological therapy in association with surgery, found that women who had a willingness to have psychological treatment were more likely to have an improved outcome following surgery 38 . Indeed, one study found that a combination of surgery and heterogeneous behavioural sex therapy techniques were not signi® cantly better than behavioural sex therapy alone in relieving pain 51 . Although Abramov 37 advocates the treatment of vaginismus prior to surgery others have not found vaginismus to be an important factor in treatment 38 . Associated psychosexual problems, as a result of vulvar vestibulitis, should always be considered and support should be available when sexual dysfunction or relational problems are present 51, 52 .
THE FUTURE
There is a great need for further research on all aspects of vulvar vestibulitis. Studies should include assessment of pain on examination (some advocate the use of a probe) 53 and also selfreported pain assessment. Treatment trials need to be randomized and controlled. Better prevalence studies are required and psychosexual problems require investigation.
Bergeron 50 advocates that pain, sexual dysfunction, daily activities and relationship adjustment all need to be addressed. To do this, the ® rst step must be that patients with this distressing and debilitating syndrome are accurately diagnosed and referred, and this can only be achieved by greater physician, healthcare worker, therapist and patient awareness of the condition.
